Link2Trials

What Link2Trials does

Link2Trials B.V., founded in 2007 and headquartered in Hilversum, Netherlands, is a full-service clinical trial recruitment and adherence company serving pharmaceutical sponsors, contract research organizations, academic medical centers and consumer-goods research teams. Its service portfolio spans four core offerings: Patient Feasibility Study (protocol optimization consulting), Patient Recruitment & Pre-qualification (identifying eligible participants), e-Consent (a digital consent module with video meeting scheduling and validated digital signatures), and Adherence Risk Management (personalized retention support targeting the 25% average early drop-out rate in trials). On the supply side, the company runs a consumer-facing Subject/Volunteer Registration Platform with 30+ country-specific localized domains (covering Europe, North America, South America, Asia and Oceania), through which it claims 200,000+ test subjects and participation in 1,000+ clinical trials.

The underlying technology is a clinical trial recruitment and patient management platform featuring e-consent, online pre-screening questionnaires, and adherence risk tracking, sold primarily as professional services on a quote basis with multi-year enterprise contracts, alongside subscription-style recurring services tied to the volunteer platform. Go-to-market is hybrid: direct sales-led engagement with pharmaceutical sponsors and research sites for recruitment and feasibility services, combined with a direct-to-consumer self-serve web channel that funnels registered volunteers to sponsor trials. Distribution leverage is supported by SEO-driven country domains, content marketing, and engagement with patient advocacy groups; the firm is also an Associated Partner in the EFPIA-IMI patient adherence initiative and a participant in the EU-funded BEAMER project.

Link2Trials B.V. operates as a privately-held Dutch BV with no disclosed parent company, institutional investors or external funding rounds. Its named customer base includes Pfizer, GSK, Novartis, Bayer, Boehringer Ingelheim, Unilever, AMC, Castor, Gedea and Julius. It has 11-50 employees and no disclosed AI/ML capabilities, patents or public API integrations.

Name

Link2Trials

Legal name

Link2Trials B.V.

Website

https://link2trials.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Link2Trials is a Dutch full-service clinical trial recruitment and adherence company that runs patient feasibility, recruitment, e-consent and adherence services for pharmaceutical sponsors and research sites, supported by a 30-country volunteer registration platform with 200,000+ registered subjects.

Ownership category

akta.pro rank

Product category

Clinical Trial Patient Recruitment Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Patient Recruitment & Retention (HLAGACAD)

akta.pro secondary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical trial recruitment
• Patient recruitment services
• E-consent solutions
• Adherence management
• Patient feasibility studies

Headquarters

HQ city

Hilversum

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Recruitment Services: Link2Trials provides recruitment services to pharmaceutical companies, research sites, and clinical trial sponsors. The company helps optimize study protocols, develop effective e-consent processes, identify and recruit eligible participants, and provide personalized support to boost adherence.
2. Patient Feasibility Studies: Consulting services to help fine-tune study protocols for enhanced patient recruitment and adherence, leveraging extensive experience with investigators, research sites, and pharmaceutical professionals.
3. Volunteer Platform Services: Platform enabling volunteers to register and participate in clinical trials, connecting researchers with suitable healthy subjects or patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Link2Trials is a full-service clinical trial recruitment and adherence company that helps pharmaceutical sponsors and research sites optimize protocols, recruit and pre-qualify eligible patients, run digital e-Consent with video meetings and validated signatures, and manage adherence to reduce early drop-outs. It also operates a multi-country volunteer registration platform where healthy subjects and patients can sign up to participate in medical research across 30+ country-specific domains.

Product overview

Link2Trials is a full-service clinical trial recruitment and adherence company offering a unified platform of services. The core offerings include Patient Feasibility Study (for protocol optimization), Patient Recruitment & Pre-qualification (for identifying eligible participants), e-Consent (digital consent with video meetings and validated signatures), and Adherence Risk Management (to reduce early drop-out rates). Additionally, the platform provides a Subject/Volunteer Registration Platform enabling volunteers to register for medical research studies, supported by a Resource Library containing case studies and educational materials.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Feasibility Study A consulting-style service that helps pharmaceutical sponsors and research sites fine-tune study protocols for enhanced patient recruitment and adherence, drawing on extensive experience with investigators, research sites, and pharmaceutical professionals.
• Patient Recruitment & Pre-qualification Specialized patient recruitment and pre-qualification service for pharmaceutical companies and research sites, focused on identifying and engaging eligible participants and continuously improving the patient experience throughout the recruitment cycle.
• e-Consent A digital consent module offering easy-to-schedule e-consent video meetings with a validated digital signature process, designed to increase patient experience for both patient and research site during enrollment.
• Adherence Risk Management Service for pharmaceutical sponsors and research sites that addresses early drop-out (an extreme form of patient non-adherence), providing personalized support to boost adherence throughout the trial cycle and reduce extended timelines and budgets.
• Subject/Volunteer Registration Platform An independent platform where healthy volunteers and patients can register to participate in medical research, pharmaceutical research, psychological research, nutritional research, or testing of medical devices and products, available across 30+ country-specific domains.

Quantifiable outcome

• Average early drop-out rate in clinical trials addressed by services

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• EFPIA-IMI (European Federation of Pharmaceutical Industries and Associations - Innovative Medicines Initiative)coreStrategic or Co-development Partner · 1 January 2018Link2Trials was accepted as Associated Partner for the patient adherence improvement project under IMI Call 23, Topic 6. The partnership focuses on addressing patient non-adherence to prescribed treatment, which affects patient health outcomes.
• BEAMER ProjectminorStrategic or Co-development PartnerEuropean research initiative focused on patient engagement and clinical trial optimization. Link2Trials participates as a project partner.
• EU (European Union)minorStrategic or Co-development PartnerEuropean Union research funding and support for healthcare innovation projects in which Link2Trials participates.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• SubjectWell: SubjectWell operates a consumer-facing volunteer platform that recruits patients into clinical trials, mirroring Link2Trials' volunteer registration portal. It is a direct competitor for self-service patient-recruitment funnels used by sponsors and CROs.
• Trialbee: Trialbee provides data-driven patient recruitment, feasibility, and real-world patient insights for clinical trials. It competes head-to-head with Link2Trials in pharma-sponsored recruitment, with overlap in protocol optimization, pre-screening, and patient matching.
• BBK Worldwide: BBK Worldwide is a long-standing patient recruitment and retention agency for clinical trials, offering site engagement and patient experience services. It competes directly with Link2Trials for pharma recruitment budgets and retention contracts.
• Clariness: Clariness runs a global patient recruitment platform (ClinLife) and feasibility services similar to Link2Trials, with multi-country volunteer databases. It is one of the closest European competitors in country-specific clinical trial patient recruitment.
• Antidote (Antidote.me): Antidote operates a digital patient recruitment platform that matches patients to clinical trials across multiple therapy areas. It is a direct peer to Link2Trials, competing for the same pharma sponsors and CRO recruitment budgets with a similar patient-database-driven model.

Broad incumbents

• Parexel International: Parexel is a large global CRO providing patient recruitment, feasibility, and clinical operations across all phases. It is an incumbent alternative for sponsors that prefer to bundle recruitment inside a full-service CRO engagement.
• Syneos Health: Syneos Health is a full-service biopharma solutions organization offering clinical development and commercialization services, including patient recruitment. It competes as a broad incumbent rather than a recruitment-focused niche player.
• IQVIA: IQVIA is the largest global CRO and offers patient recruitment, feasibility, site management, and real-world data services. It competes with Link2Trials on recruitment contracts but as part of an end-to-end clinical services portfolio rather than as a specialist.
• Medable: Medable is a leading decentralized clinical trial platform that includes e-Consent, telehealth, and patient engagement modules — overlapping with Link2Trials' e-Consent and adherence offerings. It competes as a broader platform rather than a recruitment specialist.

Emerging players

• Deep 6 AI: Deep 6 AI uses AI-based patient cohort identification and trial matching to accelerate clinical trial recruitment. It is an emerging, tech-forward competitor in the same recruitment feasibility and patient-matching space as Link2Trials' pre-qualification services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/link2trials
• Xx.com/link2trials
• Facebookfacebook.com/link2trials

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Link2Trials